Moringa Acquisition Corp
Status: Deal Closed
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $115.00M |
|---|---|
| IPO Date | Feb 17, 2021 |
| CEO | Ilan Levin |
| Left Lead | EarlyBirdCapital |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 + 6 + 12 |
| IPO Sector |
Technology
Technology in Israel |
| IPO Geography | EEMEA |
| Target Company | Silexion |
| Deal Announced | Feb 22, 2024 |
| Deal Size, $M | TBD |
| Deal Sector | Healthcare |
| Deal Geography | EEMEA |
| SEC Filings | www.sec.gov |
| Approval Vote | Aug 6, 2024 |
| Amendment Vote | Aug 18, 2023 |
| Closing Date | Aug 15, 2024 |
Formerly MACA
SLXN
SLXNW
| Price | $0.32 |
|---|---|
| Last closing price | $0.23 |
| Volume, today | 199,862,956 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Moringa Acquisition Corp:
- Structure and cap table
- 7 directors & officers
- 35 filings and events
- 3 underwriters
- 1 deal advisors
- 3 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Ilan Levin | 54 | Chairman of the Board and Chief Executive Officer |
| Gil Maman | 38 | Chief Financial Officer |
| Dan Yalon | 48 | Advisor |
| Craig Marshak | 61 | Vice Chairman |
| Ruth Alon | 69 | Director |
| Michael Basch | 36 | Director |
| Eric Brachfeld | 59 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| EarlyBirdCapital | Joint BR | 4,750,000 | units |
| Moelis | Joint BR | 4,750,000 | |
| R.F. Lafferty | 500,000 | ||
| 10,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| BCMA | 3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.